Saturday, May 2, 2026

THE VAPID LIE: North Korea Forces Starving Citizens To Worship Their ‘World’s Finest’ SocialIST Hell

North Korea's Rodong Sinmun emphasizes national pride and patriotism ahead of the 9th Workers' Party Congress, showcasing various achievements.

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Unlocking Cancer Treatment: How TXN12923 Targets ULK1 for Enhanced Drug Sensitivity

Txinno Bioscience to present TXN12923, a novel ULK1 targeted protein degrader, at AACR, aiming to enhance cancer treatment efficacy.

Kyo Woon Koo

Author's Latest

Why 20 Years of Stem Cell Therapy Research Still Lacks Proven Results

Stem cell therapy shows promise but faces hurdles in clinical applications and approvals, with few successful treatments available.

Mastering U.S. Patent Risks: Essential Training for Korean Life Sciences Firms

The Korea Pharmaceutical and Bio-Pharma Association will host training on U.S. patent risks for local pharma and biotech professionals.

Mounjaro prescriptions surge 12-fold in 8 months, surpassing 200,000 monthly for the first time

Mounjaro prescriptions surged over tenfold in eight months, raising concerns about access for patients with obesity amid rising cosmetic demand.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Revolutionary Male Contraceptive: New Method Halts Sperm Production Without Hormonal Side Effects

A Cornell team developed a reversible male contraceptive, blocking sperm production without hormonal side effects, using a compound called JQ1.

2026 Supplementary Budget: Support for Vulnerable Groups and Youth Jobs in an Era of High Inflation

South Korea's Health Ministry proposes a budget increase to support vulnerable groups, but faces criticism over its relevance and effectiveness.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Record-Breaking Growth: How Yongma Logistics Achieved 423.8 Billion KRW in 2025

Yongma Logistics achieved record revenue and profit in 2025, driven by strategic enhancements in health and beauty logistics.

5 Warning Signs of Tuberculosis You Need to Know for Early Detection

As World Tuberculosis Day approaches, experts highlight symptoms and the importance of early diagnosis and treatment for tuberculosis.

Why Celltrion’s STEQEYMA Auto-Injector is a Game Changer for Autoimmune Patients in North America

Celltrion expands its Steqeyma auto-injector lineup in Canada, enhancing market competitiveness and patient accessibility in North America.

Unlocking Treatment Potential: GI-102 and Pasritamig Clinical Trial Insights

GI Innovation has filed an IND application for a clinical trial on a combination therapy for metastatic prostate cancer in South Korea and the U.S.

Understanding Neurogenic Bladder: Key Treatment Options for Asian Seniors in 2026

Neurogenic bladder affects many elderly patients. Early treatment is crucial to prevent complications. Options include catheterization and medication.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.